ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 216 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $33,576,000 | +378.1% | 361,267 | +206.3% | 0.02% | +360.0% |
| Q3 2021 | $7,023,000 | +56.4% | 117,932 | +79.1% | 0.01% | +25.0% |
| Q2 2021 | $4,490,000 | +6.7% | 65,841 | +8.5% | 0.00% | 0.0% |
| Q1 2021 | $4,210,000 | -20.4% | 60,671 | -11.8% | 0.00% | -20.0% |
| Q4 2020 | $5,287,000 | -43.9% | 68,809 | -45.4% | 0.01% | -54.5% |
| Q3 2020 | $9,431,000 | +23.9% | 126,097 | +4.3% | 0.01% | +22.2% |
| Q2 2020 | $7,613,000 | +97.3% | 120,939 | +31.6% | 0.01% | +80.0% |
| Q1 2020 | $3,859,000 | -14.3% | 91,873 | -7.3% | 0.01% | +25.0% |
| Q4 2019 | $4,501,000 | +10.0% | 99,086 | +10.8% | 0.00% | 0.0% |
| Q3 2019 | $4,092,000 | -32.9% | 89,443 | -14.0% | 0.00% | -33.3% |
| Q2 2019 | $6,101,000 | +34.5% | 104,063 | +2.8% | 0.01% | +50.0% |
| Q1 2019 | $4,536,000 | +78.0% | 101,187 | +54.6% | 0.00% | +33.3% |
| Q4 2018 | $2,549,000 | +237.6% | 65,456 | +298.9% | 0.00% | +200.0% |
| Q3 2018 | $755,000 | +19.7% | 16,409 | +13.4% | 0.00% | 0.0% |
| Q2 2018 | $631,000 | -84.7% | 14,475 | -86.2% | 0.00% | -75.0% |
| Q1 2018 | $4,129,000 | – | 104,538 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |